Mannheim, Germany

Stephanie Fesser

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.2

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Stephanie Fesser

Introduction

Stephanie Fesser, based in Mannheim, Germany, is a notable inventor recognized for her significant contributions to the field of RNA technology. With two patents to her name, her work is pivotal in advancing pharmaceutical applications and enhancing RNA stability and translation efficiency.

Latest Patents

Stephanie's latest patents reflect her expertise in in vitro transcription technologies. The first patent outlines technologies for in vitro transcription reactions that focus on the production of pharmaceutical-grade RNA, with the potential for large-scale production. The second patent is centered on 3'-UTR sequences that contribute to the stabilization of RNA, particularly mRNA, leading to improved translation efficiency. This invention highlights the modification of RNA to achieve increased transcript stability and enhances the efficacy of mRNA in various applications.

Career Highlights

Throughout her career, Stephanie Fesser has made significant strides in the biotechnology arena. She has worked with renowned companies, including BioNTech SE, a leader in mRNA-based therapies, and TRON—Translationale Onkologie an Der Universitätsmedizin Der Johannes Gutenberg-Universität Mainz GmbH, where she has contributed her expertise in RNA technology and its therapeutic applications.

Collaborations

Stephanie has collaborated with esteemed colleagues such as Andreas Kuhn and Irena Rabe. These partnerships have enabled her to further her research and innovation in the field of biotechnology, fostering an environment of collaboration that drives advancement in RNA technologies.

Conclusion

In summary, Stephanie Fesser’s inventive work stands as a testament to her dedication to improving RNA technology. Her contributions have not only helped shape the future of pharmaceutical applications but also underscore the importance of innovation in the biotechnology industry. As she continues to develop new solutions, her impact on drug development and therapeutic strategies will undoubtedly be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…